These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19195299)

  • 1. [Non-antiarrhythmic pharmacological treatment of atrial fibrillation: focus on drugs acting on the renin-angiotensin system].
    Durin O; Pedrinazzi C; Inama G
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):5S-10S. PubMed ID: 19195299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
    Durin O; Pedrinazzi C; Inama G
    J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial fibrillation and renin-angiotensin system].
    Yamashita T
    Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of renin-angiotensin system inhibitors in atrial fibrillation.
    Disertori M; Latini R; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
    Levine MJ; Schweitzer P
    Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system inhibitors and atrial fibrillation.
    Arbel Y; Glikson M
    Isr Med Assoc J; 2005 Jun; 7(6):388-91. PubMed ID: 15984384
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
    Goette A
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-antiarrhythmic drugs to prevent atrial fibrillation.
    Moro C; Hernández-Madrid A; Matía R
    Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.